Latest news

• 12 June 2019

  Helsinn to co-support a satellite symposium on current and emerging treatments of Acute Myeloid Leukemia (AML) at 24th European Hematology Association (EHA) Congress

  - Symposium will explore the landscape and potential...
• 7 June 2019

  Helsinn Group supports two events with the International Society for Cutaneous Lymphomas (ISCL) at the 24th World Congress of Dermatology

  - Cutaneous Lymphoma Meeting will update on latest...
• 4 June 2019

  Helsinn Group Announces Upcoming Presentation of Phase 3b data of NEPA (fosnetupitant / palonosetron) IV at ASCO 2019 – The NEPA IV formulation was evaluated for safety in the AC setting.

  Lugano, Switzerland, May 31, 2019 – Helsinn, a Swiss...